Relationship between vitamin D status and response to hepatitis C virus therapy
Matthew T. Kitson, Christoph Sarrazin, Pierluigi Toniutto, Stuart K. Roberts – 21 March 2015
Liver inflammation abrogates immunological tolerance induced by Kupffer cells
Felix Heymann, Julia Peusquens, Isis Ludwig‐Portugall, Marlene Kohlhepp, Can Ergen, Patricia Niemietz, Christian Martin, Nico van Rooijen, Jordi C. Ochando, Gwendalyn J. Randolph, Tom Luedde, Florent Ginhoux, Christian Kurts, Christian Trautwein, Frank Tacke – 21 March 2015
Reply
Daniel Pineda‐Tenor, Mónica García‐Álvarez, María A. Jiménez‐Sousa, Amanda Fernández‐Rodríguez, Salvador Resino – 21 March 2015
Acute‐on‐chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults
Yu Shi, Ying Yang, Yaoren Hu, Wei Wu, Qiao Yang, Min Zheng, Shun Zhang, Zhaojun Xu, Yihua Wu, Huadong Yan, Zhi Chen – 20 March 2015 – Patients with acute‐on‐chronic liver failure (ACLF) represent a heterogeneous population. The aim of the study is to identify distinct groups according to the etiologies of precipitating events. A total of 405 ACLF patients were identified from 1,361 patients with cirrhosis with acute decompensation and categorized according to the types of acute insults.
Acute‐on‐chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults
Yu Shi, Ying Yang, Yaoren Hu, Wei Wu, Qiao Yang, Min Zheng, Shun Zhang, Zhaojun Xu, Yihua Wu, Huadong Yan, Zhi Chen – 20 March 2015 – Patients with acute‐on‐chronic liver failure (ACLF) represent a heterogeneous population. The aim of the study is to identify distinct groups according to the etiologies of precipitating events. A total of 405 ACLF patients were identified from 1,361 patients with cirrhosis with acute decompensation and categorized according to the types of acute insults.
Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B
De‐Ke Jiang, Xiao‐Pin Ma, Hongjie Yu, Guangwen Cao, Dong‐Lin Ding, Haitao Chen, Hui‐Xing Huang, Yu‐Zhen Gao, Xiao‐Pan Wu, Xi‐Dai Long, Hongxing Zhang, Youjie Zhang, Yong Gao, Tao‐Yang Chen, Wei‐Hua Ren, Pengyin Zhang, Zhuqing Shi, Wei Jiang, Bo Wan, Hexige Saiyin, Jianhua Yin, Yuan‐Feng Zhou, Yun Zhai, Pei‐Xin Lu, Hongwei Zhang, Xiaoli Gu, Aihua Tan, Jin‐Bing Wang, Xian‐Bo Zuo, Liang‐Dan Sun, Jun O. Liu, Qing Yi, Zengnan Mo, Gangqiao Zhou, Ying Liu, Jielin Sun, Yin Yao Shugart, S.
Renal safety of intravenous gadolinium‐enhanced magnetic resonance imaging in patients awaiting liver transplantation
Katherine M. Shaffer, Mehul R. Parikh, Thomas M. Runge, Sebastian D. Perez, Sonali S. Sakaria, Ram M. Subramanian – 18 March 2015 – Renal dysfunction in cirrhosis carries a high morbidity and mortality. Given the potential risk of contrast‐induced nephropathy associated with iodinated intravenous contrast used in computed tomography (CT), alternate contrast modalities for abdominal imaging in liver transplant candidates need to be examined.
The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice
Patrice N. Mimche, Lauren M. Brady, Christian F. Bray, Choon M. Lee, Manoj Thapa, Thayer P. King, Kendra Quicke, Courtney D. McDermott, Sylvie M. Mimche, Arash Grakoui, Edward T. Morgan, Tracey J. Lamb – 17 March 2015 – Beyond the well‐defined role of the Eph (erythropoietin‐producing hepatocellular) receptor tyrosine kinases in developmental processes, cell motility, cell trafficking/adhesion, and cancer, nothing is known about their involvement in liver pathologies.
A gut solution for hepatic encephalopathy
Javier Vaquero, Rafael Bañares – 17 March 2015
Total tumor volume and alpha‐fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
Christian Toso, Glenda Meeberg, Roberto Hernandez‐Alejandro, Jean‐François Dufour, Paul Marotta, Pietro Majno, Norman M. Kneteman – 17 March 2015 – The selection of liver transplantation (LT) candidates with hepatocellular carcinoma (HCC) is currently validated based on Milan criteria. The use of extended criteria has remained a matter of debate, mainly because of the absence of prospective validation. The present prospective study recruited patients according to the previously proposed total tumor volume (TTV; ≤115 cm3)/alpha‐fetoprotein (AFP; ≤400 ng/mL) score.